Exin Therapeutics has AI agent select and deliver gene therapy during mouse brain surgery
Biotech startup Exin Therapeutics says an AI agent built on Anthropic's Sonnet model independently selected a gene therapy vector, dosage and brain target from 19 candidate treatments to address seizures in a mouse model of epilepsy, then operated a motorized stereotaxic rig to inject the therapy while monitoring for bleeding via camera. CEO Gabriel Ocana-Santero documented the procedure on X, noting a licensed veterinarian supervised with a physical kill switch at every irreversible step, and the mouse reportedly recovered and was seen moving normally afterward.